Belanda - Belanda - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

ecuphar n.v. - benazeprilhydrochloride - filmomhulde tablet - benazepril

Belgia - Belanda - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bayer sa-nv - levonorgestrel 30 µg - omhulde tablet - 0,03 mg - levonorgestrel 30 µg - levonorgestrel

Uni Eropa - Belanda - EMA (European Medicines Agency)

samsung bioepis nl b.v. - bevacizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; fallopian tube neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - antineoplastische middelen - aybintio in combination with fluoropyrimidine-based chemotherapy is indicated for treatment of adult patients with metastatic carcinoma of the colon or rectum. aybintio in combination with paclitaxel is indicated for first-line treatment of adult patients with metastatic breast cancer. zie rubriek 5 voor meer informatie over de status van humane epidermale groeifactorreceptor 2 (her2). 1 of the smpc. aybintio in combination with capecitabine is indicated for first-line treatment of adult patients with metastatic breast cancer in whom treatment with other chemotherapy options including taxanes or anthracyclines is not considered appropriate. patients who have received taxane and anthracyclinecontaining regimens in the adjuvant setting within the last 12 months should be excluded from treatment with aybintio in combination with capecitabine. raadpleeg sectie 5 voor meer informatie over her2-status. 1 of the smpc. aybintio, in addition to platinum-based chemotherapy, is indicated for first-line treatment of adult patients with unresectable advanced, metastatic or recurrent non-small cell lung cancer other than predominantly squamous cell histology. aybintio, in combination with erlotinib, is indicated for first-line treatment of adult patients with unresectable advanced, metastatic or recurrent non-squamous non-small cell lung cancer with epidermal growth factor receptor (egfr) activating mutations (see section 5. 1 of the smpc). aybintio in combination with interferon alfa-2a is indicated for first line treatment of adult patients with advanced and/or metastatic renal cell cancer. aybintio, in combination with carboplatin and paclitaxel is indicated for the front-line treatment of adult patients with advanced (international federation of gynecology and obstetrics (figo) stages iii b, iii c and iv) epithelial ovarian, fallopian tube, or primary peritoneal cancer (see section 5. 1 of the smpc). aybintio, in combination with carboplatin and gemcitabine or in combination with carboplatin and paclitaxel, is indicated for treatment of adult patients with first recurrence of platinum-sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor targeted agents. aybintio, in combination with topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of adult patients with platinum-resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor targeted agents (see section 5. 1 of the smpc). aybintio, in combination with paclitaxel and cisplatin or, alternatively, paclitaxel and topotecan in patients who cannot receive platinum therapy, is indicated for the treatment of adult patients with persistent, recurrent, or metastatic carcinoma of the cervix (see section 5. 1 of the smpc).

Uni Eropa - Belanda - EMA (European Medicines Agency)

mylan ire healthcare limited - bevacizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; fallopian tube neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - antineoplastische middelen - treatment of carcinoma of the colon or rectum, breast cancer, non-small cell lung cancer, renal cell cancer, epithelial ovarian, fallopian tube or primary peritoneal cancer, and carcinoma of the cervix.

Belanda - Belanda - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

n.v. organon (kloosterstraat 6) kloosterstraat 6 5349 ab oss - lynestrenol 0,5 mg/stuk - tablet - amylopectin (ri) ; lactose 1-water ; magnesiumstearaat (e 470b) ; potato starch (ri), - lynestrenol

Uni Eropa - Belanda - EMA (European Medicines Agency)

merck europe b.v. - choriogonadotropine alfa - anovulation; reproductive techniques, assisted; infertility, female - geslachtshormonen en modulatoren van het genitale systeem, - ovitrelle is geïndiceerd voor de behandeling van:vrouwen die superovulation voorafgaand aan geassisteerde reproductieve technieken zoals in vitro fertilisatie (ivf): ovitrelle wordt toegediend aan trigger laatste folliculaire rijping en luteinisation na stimulatie van de folliculaire groei;anovulatory of oligo-ovulatoire vrouwen: ovitrelle wordt toegediend aan trigger ovulatie en luteinisation in anovulatory of oligo-ovulatoire patiënten na stimulatie van de folliculaire groei.

Belanda - Belanda - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

guerbet 15 rue des vanesses 93420 villepinte (frankrijk) - vetzuurethylesters, gejodeerd samenstelling overeenkomend met ; ; jodium (moleculair) 480 mg/ml - oplossing voor injectie - stikstof (head space) (e 941), - ethyl esters of iodised fatty acids

Belgia - Belanda - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

elanco - levend, geattenueerd, newcastle disease virus min. 10exp6.0 eid50/dose - max. 10exp7.2 eid50/dose - lyofilisaat voor suspensie - geattenueerd pseudovogelpestvirus (newcastle diseaese) - avian infectious bursal disease virus (gumboro disease) - pluimvee

Uni Eropa - Belanda - EMA (European Medicines Agency)

merck europe b.v.  - lutropine alfa - ovulation induction; infertility, female - geslachtshormonen en modulatoren van het genitale systeem, - luveris in combinatie met een follikelstimulerend hormoon (fsh) -preparaat wordt aanbevolen voor de stimulatie van de follikelontwikkeling bij vrouwen met ernstig luteïniserend hormoon (lh) en fsh-deficiëntie. in klinische studies, deze patiënten werden gedefinieerd door een endogene serum lh niveau.

Belanda - Belanda - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

bayer b.v. - levonorgestrel; - afleveringsysteem voor intra-uterien gebruik - plastic iud with progestogen